Dedicare AB (FRA:CL6) Research & Development: €0.0 Mil (TTM As of Mar. 2026)


FRA:CL6 Dedicare AB FRA:CL6
76 GF Score
Price €4.01
GF Value €4.08
! 7 Warning Signs
View Full Analysis

What is Dedicare AB Research & Development?

Dedicare AB FRA:CL6 -1.47% 76 Research & Development is €0.0 Mil as of Mar. 2026. GuruFocus rates FRA:CL6 with a GF Score™ of 76/100 and a GF Value™ of €4.08. The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Dedicare AB's Research & Development for the three months ended in Mar. 2026 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0.0 Mil.

Dedicare AB  (FRA:CL6) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Dedicare AB Research & Development Related Terms

Dedicare AB Research & Development Historical Data

* Premium members only.

The historical data trend for Dedicare AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dedicare AB Research & Development Chart

Dedicare AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Dedicare AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:CL6
76GF Score
Dedicare AB FRA:CL6
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dedicare AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.0 Mil mean?
Dedicare AB (FRA:CL6) has a Research & Development of €0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Dedicare AB and its competitors.
Is Dedicare AB's Research & Development too high?
Dedicare AB's current Research & Development is €0.0 Mil. Overall, Dedicare AB has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Dedicare AB's Research & Development compare to KFY and RHI?
Dedicare AB's Research & Development of €0.0 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Business Services company?
A good Research & Development depends on the Business Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Dedicare AB and its competitors. Dedicare AB's current Research & Development is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dedicare AB stock overvalued right now?
Dedicare AB (FRA:CL6) has a current Research & Development of €0.0 Mil. The stock's GF Value™ is €4.08, compared to a current price of €4.01 — trading 1.7% below its estimated fair value. The current Research & Development is €0.0 Mil. Dedicare AB's overall GF Score™ is 76/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Dedicare AB (FRA:CL6), the current Research & Development is €0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dedicare AB (FRA:CL6) Overvalued in 2026?

Based on GuruFocus' analysis, Dedicare AB stock appears to be undervalued. The current stock price of €4.01 is trading 1.7% below its estimated GF Value™ of €4.08.

Key valuation signals for FRA:CL6:

  • Research & Development: €0.0 Mil
  • GF Value™: €4.08 vs. price of €4.01 (1.7% below fair value)
  • GF Score™: 76/100 with 7 warning signs

No single metric tells the full story. See the FRA:CL6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dedicare AB Business Description

Other Exchanges DEDI:Sweden0P3K:UK
Address Dalagatan 100, 5th Floor, Stockholm, SWE, 113 43
Dedicare AB is engaged in providing staffing and recruitment services within the healthcare and social care sectors. The company supplies qualified healthcare professionals, including doctors and nurses, as well as personnel such as social workers, psychologists, and other specialists in social care. Its geographical segments include Sweden (including Finland), Norway, Denmark, and the United Kingdom, from which it generates the majority of its revenue from Norway.
76GF Score

Get the complete analysis for FRA:CL6

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.01
Price
€4.08
GF Value